Esophageal cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 38: Line 38:
Shown below is an image depicting the delay-adjusted [[incidence]] and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011.  These graphs are adapted from [[SEER]]: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
Shown below is an image depicting the delay-adjusted [[incidence]] and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011.  These graphs are adapted from [[SEER]]: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>


<figure-inline><figure-inline><figure-inline>[[Image:delay adjusted incidence of invasive esophageal cancer by gender and race in the United States.PNG|824x824px]]</figure-inline></figure-inline></figure-inline>
<figure-inline><figure-inline><figure-inline><figure-inline>[[Image:delay adjusted incidence of invasive esophageal cancer by gender and race in the United States.PNG|824x824px]]</figure-inline></figure-inline></figure-inline></figure-inline>


===Race===
===Race===
Line 55: Line 55:
Shown below is an image depicting the incidence of invasive esophageal cancer by race in the United States between 1975 and 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
Shown below is an image depicting the incidence of invasive esophageal cancer by race in the United States between 1975 and 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>


<figure-inline><figure-inline><figure-inline>[[Image:Incidence of invasive esophageal cancer by race in the United States.PNG|469x469px]]</figure-inline></figure-inline></figure-inline>
<figure-inline><figure-inline><figure-inline><figure-inline>[[Image:Incidence of invasive esophageal cancer by race in the United States.PNG|469x469px]]</figure-inline></figure-inline></figure-inline></figure-inline>
<small> API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native</small>
<small> API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native</small>


Revision as of 19:24, 14 December 2017

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer epidemiology and demographics

CDC on Esophageal cancer epidemiology and demographics

Esophageal cancer epidemiology and demographics in the news

Blogs on Esophageal cancer epidemiology and demographics

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2] Hadeel Maksoud M.D.[3]

Overview

Esophageal cancer is the 6th leading cause of death from cancer and the 8th most common cancer in the world. In the United States, about 17000 new cases are diagnosed every year and 4.45 per 100,000 Americans has esophageal cancer. Esophageal cancer is mostly present in the "Asian belt" region which includes, Chin, Japan, India and Iran.

Epidemiology and Demographics

  • Worldwide, the predominant type of esophageal cancer is squamous cell carcinoma. However, the rate of adenocarcinoma outnumbers squamous cell carcinoma in the United States and some European countries.[1]
  • Estimated new cases and deaths from esophageal cancer in the United States in 2012:
    • New cases: 16,940
    • Deaths: 15,690

Prevalence

  • The prevalence of esophageal cancer differs among countries. In fact, esophageal cancer is most common in the area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.[2]
  • In the United States, the age-adjusted prevalence of invasive esophageal cancer is 8.6 per 100,000 in 2011.[3]

Incidence

  • In 2011, the age-adjusted incidence of invasive esophageal cancer was 4.45 per 100,000 persons in the United States.[3]

Age

  • The risk of esophageal cancer increases with age.
  • While the overall age-adjusted incidence of invasive esophageal cancer in the United States between 2007 and 2011 is 4.4 per 100,000, the age-adjusted incidence of invasive esophageal cancer by age category is:[3]
    • Under 65 years: 1.8 per 100,000
    • 65 and over: 22.5 per 100,000

Gender

  • In the United States, the age-adjusted prevalence of invasive esophageal cancer by gender in 2011 is:[3]
    • In males: 0.0147%
    • In females: 0.0036%
  • In the United States, the delay-adjusted incidence of invasive esophageal cancer by gender in 2011 is:[3]
    • In males: 7.83 per 100,000 persons
    • In females: 1.83 per 100,000 persons

Shown below is an image depicting the delay-adjusted incidence and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[3]

<figure-inline><figure-inline><figure-inline><figure-inline></figure-inline></figure-inline></figure-inline></figure-inline>

Race

  • While squamous cell carcinoma is more common among black individuals, adenocarcinoma is more common among caucasians.[1]
  • In the United States, 68.5% of caucasian subjects with esophageal cancer had adenocarcinoma, whereas 80% of black individuals affected with esophageal cancer had squamous cell carcinoma.[3][4]
  • Shown below is a table depicting the age-adjusted prevalence of invasive esophageal cancer by race in 2011 in the United States.[3]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence per 100,000 8.6 9.4 7 4.7 4.8

Shown below is an image depicting the incidence of invasive esophageal cancer by race in the United States between 1975 and 2011.[3]

<figure-inline><figure-inline><figure-inline><figure-inline></figure-inline></figure-inline></figure-inline></figure-inline> API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

Percent Distribution of Invasive Esophageal Cancer by Histology

Among patients with histologically confirmed cases of invasive esophageal cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:[3]

References

  1. ↑ 1.0 1.1 Zhang Y (2013). "Epidemiology of esophageal cancer". World J Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  2. ↑ Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013). "Oesophageal carcinoma". Lancet. 381 (9864): 400–12. doi:10.1016/S0140-6736(12)60643-6. PMID 23374478.
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  4. ↑ Siegel RL, Miller KD, Jemal A (2017). "Cancer Statistics, 2017". CA Cancer J Clin. 67 (1): 7–30. doi:10.3322/caac.21387. PMID 28055103.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Esophageal_cancer_epidemiology_and_demographics&oldid=1407227"